January 14, 2025 — The U.S. Food and Drug Administration (FDA) has issued new guidelines for protein analog producers in order to support the fast-growing sector.
The guidance most pertinent to the alt-protein industry is around how to label plant-based analogs of foods that are traditionally animal-derived, like alt-seafood. The FDA shared a draft guidance document on this topic, allowing citizens to submit comments on the language until 7 May 2025.